• UCSBgauchos twitter avatar
    No. 7 UCSB Carries Five-Goal First Quarter to 8-5 Win Over No. 6 LBSU https://t.co/1y3b5J18x0
    5 hours 48 min ago
  • ucsantabarbara twitter avatar
    #UCSB researchers find inspiration on the campus beach to help create a high-quality coating for organic electronics https://t.co/mgrJEQUW8E
    11 hours 34 min ago
  • ArtsandLectures twitter avatar
    Love reading about @solgabetta's love affair with the cello! https://t.co/NSkuBTry2q
    13 hours 6 min ago
  • UCSBgauchos twitter avatar
    .@UCSBMensSoccer vs. Cal Poly will kick off at 8 PM Saturday! Match can be streamed via the Fox Sports Go app! #GoGauchos
    14 hours 12 min ago
  • UCSBgauchos twitter avatar
    .@UCSBMensSoccer set to face Blue-Green rival Cal Poly on #PrimeTicket w/ Division Title on the line! PREVIEW >>>… https://t.co/pKL5mWot5z
    14 hours 13 min ago
  • ArtsandLectures twitter avatar
    We had a blast bringing Telluride @Mountainfilm to VADA @SBHS_Dons #vadasbhs! Catch the public screening tonight at… https://t.co/NmNTPPmDjE
    16 hours 13 min ago
  • brenucsb twitter avatar
    UC research goes global: @UCSD research has led to a landmark deal aimed at slowing global warming https://t.co/X25mocPX0Y
    18 hours 3 min ago

UCSB Postdoctoral Researcher Wins Fellowship

Monday, June 9, 2003 - 17:00
Santa Barbara, CA

Tina M. Trnka, a postdoctoral researcher at the University of California, Santa Barbara, has won a fellowship awarded by the Damon Runyon Cancer Research Foundation, among only fourteen awarded nationally.

According to the foundation, "The recipients of this prestigious award are outstanding young scientists conducting theoretical and experimental research that is relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention."

Trnka works in the lab of Galen Stucky, professor of chemistry and materials. She explained that there is a great need for improved chemotherapy treatments to combat cancer. "One strategy, the targeted delivery of drug molecules to specific cancer cells, aims to both enhance the effectiveness of these drugs and alleviate their toxicity to healthy cells. However, this concept has been difficult to implement because of problems with the stability, activity, selectivity, or delivery of many drug carrier combinations."

Trnka's research is an attempt to use state-of-the-art, nano-sized, composite materials for the delivery of drugs to cancer cells. The goal is to load nano-scale hollow spheres with doses of chemotherapy agents. Trnka's research proposal targets cocktails of multiple drugs to ovarian cancer cells.

She will receive $128,500 over a three year period, with some of the money going toward travel to professional meetings and research equipment and supplies.

"It's a real honor and incredible opportunity to have the support of the Damon Runyon foundation," said Trnka.

Some awards are sponsored by specific donors, and Trnka's sponsor is Cheryl Breetwor, founder of ShareData, Inc., which was acquired by E*Trade in 1998. Trnka has already met with Breetwor and with the executive director of the foundation.